The Claim

Adenosine A(2A) receptor antagonists, but not A(1) receptor antagonists, replicate the neuroprotective effect of caffeine against beta-amyloid-induced neuronal toxicity in cultured cells.

Source: Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
7score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Caffeine helps protect brain cells from a harmful protein linked to Alzheimer’s, and scientists think it’s because of a specific part of caffeine’s action—other similar drugs that block the same part also work, but ones that block a different part don’t.

See the scientific wording

Adenosine A(2A) receptor antagonists, but not A(1) receptor antagonists, mimic the protective effect of caffeine against beta-amyloid-induced neuronal toxicity in cultured cells.

What the research says

1 study

  1. Study: Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.

    The study found that blocking the A(2A) brain receptor, like caffeine does, protects against memory damage caused by a protein linked to Alzheimer’s — just like the claim said. Blocking a different receptor (A(1)) didn’t help, which matches the claim too.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.